Nuclera is a series b startup based in United Kingdom. 3 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Nuclera is a biotechnology company developing a desktop bioprinter that enables rapid protein prototyping and drug discovery by making protein expression and characterization accessible to researchers.
Stage
series-b
Investors
3
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky